SCHEMBL1421774

SCHEMBL1421774

COc1cc(-c2oc3cc(OCc4ccccc4)ccc3c(=O)c2OBr)ccc1OCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.61
KDM4E B2RXH2 3/20 0.53
ALDH1A1 P00352 3/20 0.53
HPGD P15428 3/20 0.53
MEN1 O00255 2/20 0.53
CYP3A4 P08684 2/20 0.53
MAPT P10636 2/20 0.53
KMT2A Q03164 2/20 0.53
HSD17B10 Q99714 2/20 0.53
THRB P10828 1/20 0.53
PPARG P37231 1/20 0.52
MAOB P27338 4/20 0.50
ABCB1 P08183 1/20 0.50
ACHE P22303 1/20 0.50
CYP19A1 P11511 2/20 0.49
NPC1 O15118 1/20 0.49
MAOA P21397 1/20 0.49
CASP3 P42574 1/20 0.49
RAB9A P51151 1/20 0.49
SENP8 Q96LD8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4153233 0.92 ABCG2 (0.63) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL25022832 0.85 ABCG2 (0.73) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL1180724 0.85 ABCG2 (0.51) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL4150940 0.85 ABCG2 (0.48) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL4150944 0.84 MAOB (0.51) ABCG2MAPTPPARGMAOBABCB1
SCHEMBL4250813 0.84 ABCG2 (0.57) ABCG2KDM4EALDH1A1HPGDMAPT
SCHEMBL7548319 0.83 MAOB (0.48) ABCG2MAOBABCB1ACHENPC1
SCHEMBL4167435 0.82 ABCG2 (0.70) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL1422889 0.82 ABCG2 (0.47) ABCG2KDM4EALDH1A1HPGDMEN1
SCHEMBL117674 0.82 MAOB (0.50) ABCG2PPARGMAOBABCB1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2297127-A1 CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AxoGlia Therapeutics S.A. (LU) 2011-03-23 EP disclosed
WO-2009130253-A1 CHROMENONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES AXOGLIA THERAPEUTICS S.A. (LU) 2009-10-29 WO disclosed